B. Riley analyst Jeff Van Sinderen lowered the firm’s price target on Biote (BTMD) to $3 from $4 and keeps a Neutral rating on the shares. The firm reduced estimates post the Q3 report.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTMD: